Reducing Unintentional Injuries in the First Two Years of Life: A Randomized Controlled Trial of the AAP’s The Injury Prevention Program (TIPP)

Sunday, April 24, 2022

1:15 PM – 1:30 PM US MT

Location: Convention Center: Mile High Ballroom 4CD

CE: Enduring CME: 0.25

Publication Number: 2470.2

Eliana M. Perrin, Johns Hopkins School of Medicine, Baltimore, MD, United States; Asheley Skinner, Duke University School of Medicine, Durham, NC, United States; Lee Sanders, Stanford University, Stanford, CA, United States; Russell L. Rothman, Vanderbilt University Medical Center, Nashville, TN, United States; Shari Barkin, Vanderbilt University Medical Center, Nashville, TN, United States; Tamera Coyne-Beasley, University of Alabama at Birmingham, Birmingham, AL, United States; Jonathan Schildcrout, Vanderbilt University Medical Center, Nashville, TN, United States; aihua Bian, Vanderbilt Medical Center, Nashville, TN, United States; Alan M. Delamater, University of Miami Leonard M. Miller School of Medicine, Miami, FL, United States; Kori Flower, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States; William Heerman, Vanderbilt University Medical Center, Nashville, TN, United States; H. Shonna Yin, NYU Grossman School of Medicine, New York City, NY, United States

Presenting Author(s)

Eliana M. Perrin, MD, MPH
Bloomberg Distinguished Professor
Johns Hopkins School of Medicine
Baltimore, Maryland, United States

Full Presentation

Participants should be aware of the following financial/non-financial relationships:

Eliana M. Perrin, MD, MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Asheley Skinner, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Lee Sanders, MD, MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Russell Rothman, MD MPP: ● Moderna (Currently Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).

Shari Barkin, MD, MSHS: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Tamera Coyne-Beasley, MD, MPH: ● Dynavax (Products/Services: Advisory Committee).
● Moderna (Currently Ongoing) (Products/Services: Advisory Committee).
● Pfizer (Currently Ongoing) (Products/Services: Advisory Committee).
● Sanofi Pasteur (Currently Ongoing) (Products/Services: Advisory Committee).

Jonathan Schildcrout, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

aihua bian, MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Alan M. Delamater, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Kori Flower, MD MS MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.

William Heerman, MD MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.

H. Shonna Yin, MD, MS: I do not have any relevant financial / non-financial relationships with any proprietary interests.